{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Currier JS"],"funding":["National Institute of Allergy and Infectious Diseases","NIAID NIH HHS","National Institutes of Health","NIH HHS"],"pagination":["S77-S82"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC10469341"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["228(Suppl 2)"],"pubmed_abstract":["Clinical Trials Registration ClinicalTrials.gov Identifier: NCT04518410."],"journal":["The Journal of infectious diseases"],"pubmed_title":["ACTIV-2: A Platform Trial for the Evaluation of Novel Therapeutics for the Treatment of Early COVID-19 in Outpatients."],"pmcid":["PMC10469341"],"funding_grant_id":["UM1 AI069423","UM1 AI106701","U01 AI068636","UM1 AI069424","UM1 AI068634","UM1AI068636","UM1AI068634","UM1AI106701","U01 AI069424","UM1 AI069463","UM1 AI069432"],"pubmed_authors":["Waring L","Hosey L","Science F","Erhardt B","ACTIV-2/A5401 Study Team","Chew KW","Moser C","Smith DM","Javan AC","Eron JJ","Wohl DA","Patel N","Adams S","Currier JS","Daar ES","Roa J","Hessinger D","Hughes MD"],"additional_accession":[]},"is_claimable":false,"name":"ACTIV-2: A Platform Trial for the Evaluation of Novel Therapeutics for the Treatment of Early COVID-19 in Outpatients.","description":"Clinical Trials Registration ClinicalTrials.gov Identifier: NCT04518410.","dates":{"release":"2023-01-01T00:00:00Z","publication":"2023 Aug","modification":"2026-04-07T14:54:16.964Z","creation":"2024-10-16T14:39:00.754Z"},"accession":"S-EPMC10469341","cross_references":{"pubmed":["37650231"],"doi":["10.1093/infdis/jiad246"]}}